FEEDBACK PLC LS-5
Feedback plc provides software and systems to those working in the field of medical imaging. The company's products include Bleepa, an image-based communication platform for frontline clinicians; CareLocker, a patient-centric cloud architecture; and Feedback Connect that enables imaging-led point-of-care decision making in remote areas. The company was incorporated in 1958 and is based in London,… Read more
FEEDBACK PLC LS-5 (GZM0) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FEEDBACK PLC LS-5 (GZM0) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FEEDBACK PLC LS-5 - Net Assets Trend (None–None)
This chart illustrates how FEEDBACK PLC LS-5's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FEEDBACK PLC LS-5 (None–None)
The table below shows the annual net assets of FEEDBACK PLC LS-5 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FEEDBACK PLC LS-5's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FEEDBACK PLC LS-5 Competitors by Market Cap
The table below lists competitors of FEEDBACK PLC LS-5 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Saga Furs Oyj C
HE:SAGCV
|
$5.06 Million |
|
Novita S.A.
WAR:NVT
|
$5.06 Million |
|
Hexagon Resources Ltd
AU:HXG
|
$5.06 Million |
|
Amj Land Holdings Limited
NSE:AMJLAND
|
$5.06 Million |
|
Ben Tre Pharmaceutical JSC
VN:DBT
|
$5.06 Million |
|
PT Superior Prima Sukses Tbk
JK:BLES
|
$5.05 Million |
|
CV Sciences Inc
OTCQB:CVSI
|
$5.05 Million |
|
SA Corporate Real Estate Fund Managers Ltd
JSE:SAC
|
$5.05 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FEEDBACK PLC LS-5's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FEEDBACK PLC LS-5's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FEEDBACK PLC LS-5 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FEEDBACK PLC LS-5's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $1,807,324,866
- Average return on equity (ROE) among peers: -12.22%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FEEDBACK PLC LS-5 (GZM0) | €- | N/A | N/A | $5.06 Million |
| Schrödinger, Inc. (43Z) | $557.09 Million | -18.02% | 0.36x | $619.47 Million |
| DACHA STRATEGIC (7DC) | $40.24 Million | 0.65% | 0.08x | $81.97 Million |
| ABL Diagnostics Société anonyme (9BK0) | $6.77 Million | 0.80% | 1.20x | $379.13K |
| Zhejiang Taimei Medical Technology Co., Ltd. (A2V) | $1.04 Billion | -33.28% | 0.39x | $47.24 Million |
| ASCOM HLDG NA SF 0,50 (AH2N) | $80.00 Million | 16.88% | 1.43x | $190.62 Million |
| DocCheck AG (AJ91) | $18.14 Million | 3.32% | 0.15x | $18.00 Million |
| EM Systems Co. Ltd (EMO) | $17.69 Billion | 7.87% | 0.33x | $74.55 Million |
| Tempus AI (F3M) | $-1.38 Billion | 0.00% | 0.00x | $4.69 Billion |
| Pangenomic Health Inc. (LL3) | $2.24 Million | -118.14% | 0.15x | $4.82 Million |
| MeVis Medical Solutions AG (M3V) | $17.83 Million | 17.76% | 0.45x | $12.50 Million |